Market Alert: Trump’s Tariff Policy Pressures Healthcare Stocks
1. ASX Outlook
2. Overnight US Markets:
Wall Street was modestly higher: S&P 500 up 0.41%, Dow +0.18%, Nasdaq +0.30%, while the Russell 2000 gained just 0.05%.
The Dow hit a fresh record high, while the S&P 500 extended its upward momentum.
3. US Sector Performance
Healthcare led the way with +2.45%, while Tech and Industrials also saw solid gains. Energy (-1.07%) and Financials (-0.45%) lagged.
4. Commodities
5. ASX Today – Key Headlines
China has banned new BHP iron ore cargoes amid a pricing dispute. While ADRs fell intraday, they recovered much of the losses, ending only 0.8% lower. The ban looks unsustainable given BHP supplies 12% of China’s imports.
Star Entertainment (SGR) reported a FY25 normalised net loss of $215.5m, slightly better than its unaudited estimate of $259m.
6. Stocks Trading Ex-Dividend
Today, stocks trading ex-dividend include:
Cedar Woods Properties (CWP) – $0.19, Nick Scali (NCK) – $0.33).
7. Broker Moves
Macquarie Technology Group was initiated as Outperform by Macquarie with a $97.30 price target.
8. Macro-Economic Calendar -few key announcements
9:00 am – Australia Ai Group Industry Index (Sep)
7:00 pm – Eurozone Inflation (Sep)
12:00 am – US ISM Manufacturing PMI (Sep)
Our take at Kapitales Research:
The ASX looks set for a cautious open, tracking softer US tech sentiment and lower oil. However, record US benchmarks and strength in healthcare and gold could offer some support. BHP headlines will be closely watched today, but we see the iron ore dispute as more posturing than a lasting risk.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Sep 17, 2025
Sep 15, 2025
Sep 10, 2025
Aug 23, 2025
Aug 12, 2025
Apr 14, 2025
Apr 04, 2023
Mar 28, 2022
Mar 08, 2022
Mar 08, 2022
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.